Earnings results for Verastem (NASDAQ:VSTM)
Verastem, Inc. is estimated to report earnings on 03/17/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.51.
Analyst Opinion on Verastem (NASDAQ:VSTM)
1 Wall Street analysts have issued ratings and price targets for Verastem in the last 12 months. Their average twelve-month price target is $3.00, predicting that the stock has a possible upside of 29.87%. The high price target for VSTM is $3.00 and the low price target for VSTM is $3.00. There are currently 1 buy rating for the stock, resulting in a consensus rating of “Buy.”
Verastem has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings. According to analysts’ consensus price target of $3.00, Verastem has a forecasted upside of 29.9% from its current price of $2.31. Verastem has received no research coverage in the past 90 days.
Dividend Strength: Verastem (NASDAQ:VSTM)
Verastem does not currently pay a dividend. Verastem does not have a long track record of dividend growth.
Insiders buying/selling: Verastem (NASDAQ:VSTM)
In the past three months, Verastem insiders have not sold or bought any company stock. Only 2.90% of the stock of Verastem is held by insiders. 42.15% of the stock of Verastem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.
Earnings and Valuation of Verastem (NASDAQ:VSTM
Earnings for Verastem are expected to grow in the coming year, from ($0.38) to ($0.27) per share. The P/E ratio of Verastem is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Verastem is -1.64, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Verastem has a P/B Ratio of 25.67. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.
More latest stories: here